120 related articles for article (PubMed ID: 1847661)
1. Synergy between hepatitis B virus expression and chemical hepatocarcinogens in transgenic mice.
Sell S; Hunt JM; Dunsford HA; Chisari FV
Cancer Res; 1991 Feb; 51(4):1278-85. PubMed ID: 1847661
[TBL] [Abstract][Full Text] [Related]
2. Hepatocarcinogenesis due to chronic liver cell injury in hepatitis B virus transgenic mice.
Dunsford HA; Sell S; Chisari FV
Cancer Res; 1990 Jun; 50(11):3400-7. PubMed ID: 1692259
[TBL] [Abstract][Full Text] [Related]
3. High-level expression of hepatitis B virus HBx gene and hepatocarcinogenesis in transgenic mice.
Koike K; Moriya K; Iino S; Yotsuyanagi H; Endo Y; Miyamura T; Kurokawa K
Hepatology; 1994 Apr; 19(4):810-9. PubMed ID: 8138251
[TBL] [Abstract][Full Text] [Related]
4. Activation of multidrug resistance (P-glycoprotein) mdr3/mdr1a gene during the development of hepatocellular carcinoma in hepatitis B virus transgenic mice.
Kuo MT; Zhao JY; Teeter LD; Ikeguchi M; Chisari FV
Cell Growth Differ; 1992 Aug; 3(8):531-40. PubMed ID: 1356418
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis B injury, male gender, aflatoxin, and p53 expression each contribute to hepatocarcinogenesis in transgenic mice.
Ghebranious N; Sell S
Hepatology; 1998 Feb; 27(2):383-91. PubMed ID: 9462635
[TBL] [Abstract][Full Text] [Related]
6. Increased sensitivity to the hepatocarcinogen diethylnitrosamine in transgenic mice carrying the hepatitis B virus X gene.
Slagle BL; Lee TH; Medina D; Finegold MJ; Butel JS
Mol Carcinog; 1996 Apr; 15(4):261-9. PubMed ID: 8634084
[TBL] [Abstract][Full Text] [Related]
7. Synergy between transforming growth factor alpha and hepatitis B virus surface antigen in hepatocellular proliferation and carcinogenesis.
Jakubczak JL; Chisari FV; Merlino G
Cancer Res; 1997 Aug; 57(16):3606-11. PubMed ID: 9270035
[TBL] [Abstract][Full Text] [Related]
8. Hepatic preneoplasia in hepatitis B virus transgenic mice.
Toshkov I; Chisari FV; Bannasch P
Hepatology; 1994 Nov; 20(5):1162-72. PubMed ID: 7927248
[TBL] [Abstract][Full Text] [Related]
9. Strong, sustained hepatocellular proliferation precedes hepatocarcinogenesis in hepatitis B surface antigen transgenic mice.
Huang SN; Chisari FV
Hepatology; 1995 Mar; 21(3):620-6. PubMed ID: 7875658
[TBL] [Abstract][Full Text] [Related]
10. Interactive effects of chemical carcinogens and hepatitis B virus in the pathogenesis of hepatocellular carcinoma.
Harris CC; Sun TT
Cancer Surv; 1986; 5(4):765-80. PubMed ID: 3040243
[TBL] [Abstract][Full Text] [Related]
11. Hepatic neoplasms in aflatoxin B1-treated, congenital duck hepatitis B virus-infected, and virus-free pekin ducks.
Cullen JM; Marion PL; Sherman GJ; Hong X; Newbold JE
Cancer Res; 1990 Jul; 50(13):4072-80. PubMed ID: 1972346
[TBL] [Abstract][Full Text] [Related]
12. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
[TBL] [Abstract][Full Text] [Related]
13. Pre-S mutant surface antigens in chronic hepatitis B virus infection induce oxidative stress and DNA damage.
Hsieh YH; Su IJ; Wang HC; Chang WW; Lei HY; Lai MD; Chang WT; Huang W
Carcinogenesis; 2004 Oct; 25(10):2023-32. PubMed ID: 15180947
[TBL] [Abstract][Full Text] [Related]
14. Hepatocarcinogenesis is the sequel to hepatitis in Z#2 alpha 1-antitrypsin transgenic mice: histopathological and DNA ploidy studies.
Geller SA; Nichols WS; Kim S; Tolmachoff T; Lee S; Dycaico MJ; Felts K; Sorge JA
Hepatology; 1994 Feb; 19(2):389-97. PubMed ID: 8294096
[TBL] [Abstract][Full Text] [Related]
15. The up-regulation of proteasome subunits and lysosomal proteases in hepatocellular carcinomas of the HBx gene knockin transgenic mice.
Cui F; Wang Y; Wang J; Wei K; Hu J; Liu F; Wang H; Zhao X; Zhang X; Yang X
Proteomics; 2006 Jan; 6(2):498-504. PubMed ID: 16317774
[TBL] [Abstract][Full Text] [Related]
16. [Transgenic mouse model for hepatocellular carcinoma in human hepatitis B virus infection].
Koike K
Nihon Rinsho; 1993 Feb; 51(2):536-41. PubMed ID: 8385245
[TBL] [Abstract][Full Text] [Related]
17. Collaboration between growth factors and diverse chemical carcinogens in hepatocarcinogenesis of transforming growth factor alpha transgenic mice.
Takagi H; Sharp R; Takayama H; Anver MR; Ward JM; Merlino G
Cancer Res; 1993 Sep; 53(18):4329-36. PubMed ID: 8364928
[TBL] [Abstract][Full Text] [Related]
18. Breaking tolerance leads to autoantibody production but not autoimmune liver disease in hepatitis B virus envelope transgenic mice.
Wirth S; Guidotti LG; Ando K; Schlicht HJ; Chisari FV
J Immunol; 1995 Mar; 154(5):2504-15. PubMed ID: 7868916
[TBL] [Abstract][Full Text] [Related]
19. Toxicology and Carcinogenesis Studies of 5,5-Diphenylhydantoin (CAS No. 57-41-0) (Phenytoin) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Nov; 404():1-303. PubMed ID: 12621514
[TBL] [Abstract][Full Text] [Related]
20. Oval cell proliferation in early stages of hepatocarcinogenesis in simian virus 40 large T transgenic mice.
Bennoun M; Rissel M; Engelhardt N; Guillouzo A; Briand P; Weber-Benarous A
Am J Pathol; 1993 Nov; 143(5):1326-36. PubMed ID: 7694468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
